PAVmed Inc Strategic Asset Allocation Index
PAVmed Inc strategic asset allocation index. PAVmed Inc (PAVM) has a Strategic Asset Allocation Index of 122.6% as of September 2025. Strategic assets (PP&E of $- plus long-term investments of $31.61 Million) total $31.61 Million, measured against net assets of $25.79 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See PAVM equity to assets ratio to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of PAVmed Inc (2021–2022)
Strategic asset allocation index of PAVmed Inc from 2021 to 2022. This chart shows how PAVmed Inc's Strategic Asset Allocation Index has evolved across 2 annual periods from 2021 to 2022. As of September 2025, the index stands at 122.6%, representing strategic assets of $31.61 Million against net assets of $25.79 Million USD. Check PAVM intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
PAVmed Inc Strategic Asset Allocation Index by Year (2021–2022)
PAVmed Inc strategic asset allocation index by year from 2021 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for PAVmed Inc from 2021 to 2022, covering 2 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see PAVM market cap overview.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 50.2% | $5.49 Million | $5.49 Million | $- | $10.93 Million | ▲ +48.2 pp |
| 2021 | 2.0% | $1.58 Million | $1.58 Million | $- | $79.42 Million | — |